© 2022 Doctors News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
The following is a summary of “Advance Care Planning in Serious Illness: A Narrative Review,” published in the January 2023...
Read more1. For patients with second-generation drug-eluting stents, discontinuation of dual antiplatelet therapy (DAPT) 9 months post-percutaneous coronary intervention (PCI) was...
Read moreClick here to read this study in NEJM The post #VisualAbstract: Aldosterone synthase inhibition reduced systolic blood pressure in patients with...
Read moreThe following is a summary of “Preexisting Neuropsychiatric Conditions and Associated Risk of Severe COVID-19 Infection and Other Acute Respiratory...
Read moreThe following is the summary of “Refractory Alopecia Areata and Vitiligo Responding to Tofacitinib Monotherapy” published in the December 2022...
Read moreThe following is a summary of “Durable medication-free remission of sarcoidosis following discontinuation of anti-tumor necrosis factor-α therapy,” published in...
Read moreThe following is a summary of “Decision-making from temporally accumulated conflicting evidence: The more the merrier,” published in the January...
Read moreThe following is the summary of “Impact of fluid overload on blood pressure variability in patients on peritoneal dialysis” published...
Read more1. Individuals with more severe acute COVID-19 illness and an unvaccinated status prior to infection were more likely to have...
Read more1. Global cure was achieved in 59% of the rezafungin group compared to 61% of the caspofungin group. 2. There...
Read more© 2022 Doctors News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Doctors News Hubb All rights reserved.